PRTCL / Peptides / Semaglutide vs Tirzepatide
Comparison · Updated September 2026

Semaglutide vs Tirzepatide.

Both are once-weekly injectable medicines that act on GLP-1, the gut hormone behind appetite and blood-sugar control. Tirzepatide adds a second hormone target, GIP. In the only head-to-head trial so far, Tirzepatide produced more average weight loss. Which one fits a person is a decision for their prescriber, based on health history, tolerability and coverage.

Side by side
SemaglutideTirzepatide
Brand namesOzempic, Wegovy (injection, pill and HD), RybelsusMounjaro, Zepbound
How it worksGLP-1 receptor agonistDual GIP and GLP-1 receptor agonist
Online nickname"GLP-1S""GLP-2T" (it is not a GLP-2 drug)
How it is takenWeekly injection; once-daily tablet (Rybelsus, Wegovy pill)Weekly injection
Weight-management label dose stepsWegovy: 0.25, 0.5, 1, 1.7 and 2.4 mg; Wegovy HD 7.2 mgZepbound: 2.5, 5, 7.5, 10, 12.5 and 15 mg
SURMOUNT-5 average weight loss, 72 weeks13.7%20.2%
US statusFDA-approved (prescription)FDA-approved (prescription)

What the head-to-head trial found

SURMOUNT-5, published in the New England Journal of Medicine in 2025, randomized 751 adults with obesity and without type 2 diabetes to the highest tolerated dose of Tirzepatide (10 or 15 mg) or Semaglutide (1.7 or 2.4 mg) for 72 weeks. Average weight loss was 20.2% with Tirzepatide and 13.7% with Semaglutide. Stomach side effects were the most common with both, and more people stopped Semaglutide because of them (5.6% vs 2.7%).

What has changed since

In March 2026 the FDA approved Wegovy HD, a 7.2 mg Semaglutide injection for adults who have tolerated 2.4 mg; in the STEP UP trials it produced about 20.7% average weight loss over 72 weeks. Semaglutide for weight management also comes as a once-daily Wegovy pill. These were not part of SURMOUNT-5, so the trial does not compare them.

Tracking either one

The things worth logging are the same: the weekly injection day, each titration step and its date, the injection site, supply on hand, and weight and activity over time. If a prescriber switches you from one to the other, log the switch as a new protocol step so the before and after stay readable.

Not medical advice. This page compares published facts and trial averages. It does not recommend any medicine or dose; that decision belongs to you and a licensed prescriber.
Sources
Related

All peptides · GLP-1 tracker · Peptide calculator

Questions worth answering

Common questions.

Which causes more weight loss, Semaglutide or Tirzepatide?

In the SURMOUNT-5 head-to-head trial, Tirzepatide produced 20.2% average weight loss at 72 weeks versus 13.7% for Semaglutide 2.4 mg. Results vary by person, and the higher-dose Wegovy HD 7.2 mg was not part of that trial.

Is Mounjaro the same as Ozempic?

No. Ozempic is Semaglutide, which targets GLP-1. Mounjaro is Tirzepatide, which targets both GIP and GLP-1. Both are weekly injections approved for type 2 diabetes; their weight-management versions are Wegovy and Zepbound.

Is Wegovy the same as Zepbound?

No. Wegovy is Semaglutide and Zepbound is Tirzepatide. Both are FDA-approved for chronic weight management and have different dose steps.

Can you switch from Semaglutide to Tirzepatide?

Only with your prescriber, who sets the starting dose. PRTCL logs the switch as a new protocol step so your history stays in one place.

Is Tirzepatide a GLP-2 drug?

No. "GLP-2T" is online shorthand. Tirzepatide acts on GIP and GLP-1 receptors. GLP-2 is a different hormone with its own, unrelated medicines.

Can PRTCL track Semaglutide and Tirzepatide?

Yes. PRTCL handles weekly schedules, titration history, injection-site rotation, reminders and supply, with weight and activity from Health Connect beside every dose.

Be informed. Every claim on this page links to its source. Read the studies, do your own research, and talk to a licensed healthcare provider before you start, stop or change anything. PRTCL tracks your protocol; it does not give medical advice.
Start with one protocol

Track it in one system.

PRTCL runs peptides, supplements, nutrition and training together, with reminders at the times you set, reconstitution math, site rotation and inventory that counts itself down. Launching on Android and iPhone the same day. Join the waitlist and enter the draw for one of 57 lifetime Premium subscriptions.